Novel HLA-B alleles, B*8201, B*3515 and B*5106, add to the complexity of serologic identification of HLA types

被引:21
作者
Hurley, CK
Steiner, N
Hoyer, RJ
Menchaca, E
Mitton, W
Simonis, T
Hartzman, RJ
Johnson, AH
Ng, J
机构
[1] GEORGETOWN UNIV,SCH MED,DEPT MICROBIOL & IMMUNOL,WASHINGTON,DC
[2] WILFORD HALL USAF MED CTR,LACKLAND AFB,TX 78236
[3] USN,MED RES INST,BETHESDA,MD
[4] NIH,HLA LAB,BETHESDA,MD 20892
[5] GEORGETOWN UNIV,SCH MED,DEPT PEDIAT,WASHINGTON,DC 20007
来源
TISSUE ANTIGENS | 1996年 / 47卷 / 03期
关键词
HLA-B; B*8201; B*3515; B*5106;
D O I
10.1111/j.1399-0039.1996.tb02538.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Three class I alleles, B*8201, B*3515 and B*5106, have been described using DNA and cDNA sequencing. The B*8201 allele is most structurally related to B*5602, differing from it by 14 nucleotide substitutions resulting in 5 amino acid differences. The other two alleles, B*3515 and B*5106, differ from their most closely related HLA-B alleles by 2-3 nucleotide substitutions resulting in 1-2 amino acid substitutions, respectively. The majority of nucleotide substitutions marking these new alleles are observed in other HLA-B alleles suggesting that gene conversion and/or reciprocal recombination have created this diversity. All of the amino acid substitutions are predicted to alter the antigen binding site of the HLA-B molecule. The newly defined HLA-B allelic products were originally defined by their unusual serologic reactivity patterns. The B*8201 allelic product is serologically typed as a B ''blank'' or as a variant of B22 or B45. These patterns and the serologic reactivity of the other newly described allelic products are consistent with the protein sequence homology among specific HLA-B molecules. While serology remains a powerful tool for detecting HLA diversity, alleles generated by events resulting in the sharing of HLA sequence polymorphisms among alleles at a locus will continue to create complexity in the interpretation of typing results.
引用
收藏
页码:179 / 187
页数:9
相关论文
共 29 条
[1]  
ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
[2]   EFFECT OF HLA COMPATIBILITY ON ENGRAFTMENT OF BONE-MARROW TRANSPLANTS IN PATIENTS WITH LEUKEMIA OR LYMPHOMA [J].
ANASETTI, C ;
AMOS, D ;
BEATTY, PG ;
APPELBAUM, FR ;
BENSINGER, W ;
BUCKNER, CD ;
CLIFT, R ;
DONEY, K ;
MARTIN, PJ ;
MICKELSON, E ;
NISPEROS, B ;
OQUIGLEY, J ;
RAMBERG, R ;
SANDERS, JE ;
STEWART, P ;
STORB, R ;
SULLIVAN, KM ;
WITHERSPOON, RP ;
THOMAS, ED ;
HANSEN, JA .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (04) :197-204
[3]   HLA CLASS-I NUCLEOTIDE-SEQUENCES, 1995 [J].
ARNETT, KL ;
PERHAM, P .
TISSUE ANTIGENS, 1995, 46 (3-2) :217-257
[4]   PEPTIDE CONTRIBUTES TO THE SPECIFICITY OF POSITIVE SELECTION OF CD8+ T-CELLS IN THE THYMUS [J].
ASHTONRICKARDT, PG ;
VANKAER, L ;
SCHUMACHER, TNM ;
PLOEGH, HL ;
TONEGAWA, S .
CELL, 1993, 73 (05) :1041-1049
[5]  
BEATTY PG, 1993, BLOOD, V81, P249
[6]   STRUCTURE OF THE HUMAN CLASS-I HISTOCOMPATIBILITY ANTIGEN, HLA-A2 [J].
BJORKMAN, PJ ;
SAPER, MA ;
SAMRAOUI, B ;
BENNETT, WS ;
STROMINGER, JL ;
WILEY, DC .
NATURE, 1987, 329 (6139) :506-512
[7]   PEPTIDE-INDUCED CONFORMATIONAL-CHANGES IN CLASS-I HEAVY-CHAINS ALTER MAJOR HISTOCOMPATIBILITY COMPLEX RECOGNITION [J].
BLUESTONE, JA ;
JAMESON, S ;
MILLER, S ;
DICK, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (06) :1757-1761
[8]  
BODMER JG, 1995, TISSUE ANTIGENS, V46, P1
[9]   MAJOR HISTOCOMPATIBILITY COMPLEX CONFORMATIONAL EPITOPES ARE PEPTIDE SPECIFIC [J].
CATIPOVIC, B ;
DALPORTO, J ;
MAGE, M ;
JOHANSEN, TE ;
SCHNECK, JP .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (06) :1611-1618
[10]   LOCUS-SPECIFIC AMPLIFICATION OF HLA CLASS-I GENES FROM GENOMIC DNA - LOCUS-SPECIFIC SEQUENCES IN THE FIRST AND 3RD INTRONS OF HLA-A, HLA-B, AND HLA-C ALLELES [J].
CEREB, N ;
MAYE, P ;
LEE, S ;
KONG, Y ;
YANG, SY .
TISSUE ANTIGENS, 1995, 45 (01) :1-11